CJC-1295 No-DAC (also known as Mod GRF 1-29) is a short-acting growth hormone-releasing hormone (GHRH) analog used to study the stimulation of the body's own growth hormone (GH) pulsatile secretion.
Key Features:
1. Short half-life, approximately 30 minutes.
2. Unlike CJC-1295 with DAC, it does not release cyclically.
3. More closely resembles the body's natural GH secretion rhythm.
4. Often used in conjunction with GHRP analogs such as Ipamorelin in research.
Reconstitution Method (5 mg vial)
Common Reconstitution Ratio:
1. 5 mg lyophilized powder
2. Add 3.0 mL of antibacterial water
Obtained concentration:
1. 1.67 mg/mL
2. That is, 1 mL = 1667 mcg
U-100 Insulin Injector Conversion
| Dose | Syringe Markings |
|---|---|
| 100 mcg | 6 units(0.06 mL) |
| 200 mcg | 12 units(0.12 mL) |
| 250 mcg | 15 units(0.15 mL) |
| 300 mcg | 18 units(0.18 mL) |
Example of a dose study protocol
| Cycle | Daily Dosage |
|---|---|
| Weeks 1–4 | 200 mcg |
| Weeks 5–8 | 250 mcg |
| Weeks 9–12 (Optional) | 300 mcg |
Recommended Usage Cycle
1. Common Study Cycle: 8–12 weeks
2. Can be extended or adjusted depending on study objectives
3. Injection sites need to be rotated (abdomen, legs, etc.)
4. It is recommended to inject on an empty stomach (to avoid high insulin levels interfering with GH secretion).
Storage and Stability
Unreconstituted
1. Recommended storage: -20 °C or lower (freezing)
2. Long-term storage: -80 °C
After reconstitution
1. Refrigerate at 2–8 °C
2. Avoid repeated freezing/thawing
3. Store away from light
4. Reconstitution date and concentration are recommended
Caution
1. Pour water slowly along the side of the bottle
2. Do not shake vigorously